6-Amino-7-Bromobenzothiazole

6-Amino-7-Bromobenzothiazole


    • Product Name 6-Amino-7-Bromobenzothiazole
    • Alias 6-ABB
    • Einecs 281-897-6
    • Mininmum Order 1g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    540490

    Name 6-Amino-7-Bromobenzothiazole
    Chemical Formula C7H5BrN2S
    Molar Mass 229.097 g/mol
    Appearance Solid (usually a powder)
    Melting Point Typically in a certain range (data may vary)
    Solubility In Water Low solubility
    Solubility In Organic Solvents Soluble in some organic solvents like ethanol, etc.
    Purity Can be obtained in different purity levels, e.g., 95%+, 98%+
    Density Specific density value (data may vary)
    Spectral Properties Characteristic IR, NMR spectra

    As an accredited 6-Amino-7-Bromobenzothiazole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 500g of 6 - Amino - 7 - Bromobenzothiazole packaged in a sealed, chemical - resistant bag.
    Shipping 6 - Amino - 7 - Bromobenzothiazole is shipped in well - sealed containers, following strict chemical transportation regulations. Packaged to prevent breakage and leakage, it's transported by appropriate carriers ensuring safe delivery.
    Storage 6 - Amino - 7 - Bromobenzothiazole should be stored in a cool, dry, well - ventilated area. Keep it away from heat sources, open flames, and direct sunlight. Store in a tightly sealed container to prevent moisture absorption and contact with air, which could potentially lead to chemical degradation. Separate it from oxidizing agents and incompatible substances to ensure safety.
    Application of 6-Amino-7-Bromobenzothiazole

    In the multi-step synthesis of orally administered kinase inhibitors featuring a 2-arylbenzothiazole backbone, the purification and handling of 6-Amino-7-bromobenzothiazole must conform to ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients and the requirements of 21 CFR 210/211. The compound is received as an off-white crystalline powder with a purity specification of ≥99.0% determined by HPLC (area%, detection at 254 nm) and a bromide content of 26.0–27.5% by potentiometric titration. For the pivotal Suzuki-Miyaura fragment coupling, the amine group is first protected. In a typical 500 L glass-lined reactor under nitrogen, the 6-Amino-7-bromobenzothiazole is dissolved in anhydrous THF (5–8 volumes) and treated with di-tert-butyl dicarbonate (1.08 eq) in the presence of 0.05 eq DMAP at 20–25°C for 6–8 hours to install a Boc protecting group. After aqueous work-up and crystallization from n-heptane/EtOAc, the Boc-protected intermediate is subjected to Pd-catalyzed coupling with an arylboronic acid pinacol ester using tetrakis(triphenylphosphine)palladium(0) at 0.8 mol% loading in a toluene/water biphasic system containing 2.0 eq K₂CO₃ at 80±2°C. The coupling proceeds with strict exclusion of oxygen to prevent catalyst deactivation; dissolved oxygen levels are maintained below 0.5 ppm by argon sparging. Following acid-mediated Boc deprotection (HCl in dioxane, 4.0 M, 3.0 eq) and neutralization, the crude API intermediate is crystallized from EtOH/water (70:30 v/v) to yield a polymorphically consistent material. The hydrochloride salt is then formulated into the final dosage form — typically an immediate-release tablet containing 50–200 mg of the benzothiazole-based active, embedded in a matrix of microcrystalline cellulose, croscarmellose sodium, and magnesium stearate. Compliance with ICH Q3D for elemental impurities is verified by ICP-MS per USP <232>/<233>, and residual palladium is controlled to <10 ppm. The final drug product is a potent ATP-competitive inhibitor targeting solid-tumor kinase mutations, for which the upstream intermediate’s batch-to-batch consistency and controlled regioisomeric purity (>99.5%) are critical to meeting specifications for dissolution (Q=80% in 30 min, USP Apparatus II, 50 rpm, pH 6.8 buffer).

    Why is the 7-Bromo Substituent Critical for Wash Fastness in Polyester Dyeing?

    The electron-withdrawing bromine atom at the 7-position of the benzothiazole ring significantly deepens the hue and enhances the dipole moment of the derived azo disperse dye, shifting the absorption maximum into the 570–610 nm region and boosting the dye’s substantivity for polyethylene terephthalate (PET) fibres during high-temperature exhaust dyeing. In the standardised synthesis pathway, 6-Amino-7-bromobenzothiazole is diazotised in 30% sulfuric acid using a 1.02 molar equivalent of sodium nitrite at 0–5°C, with the reaction endpoint monitored by starch-iodide paper and maintained for 2 hours to ensure complete conversion while avoiding nitrous acid decomposition. The resulting diazonium salt solution is clarified by filtration over a diatomaceous earth pad and then coupled with an N,N-dialkylaniline coupler (e.g., N,N-diethyl-m-toluidine) at a strict 1:1.00 molar ratio in an ice-water bath at 8–12°C, maintaining pH 4.8–5.2 through controlled addition of sodium acetate buffer. After coupling, the crude presscake is subjected to high-shear dispersion in a bead mill (Netzsch LMZ, 0.3 mm yttria-stabilised zirconia beads, 2000 rpm, residence time 45 min) in the presence of lignosulfonate dispersants (30–40 wt% on dry dye) until the particle size distribution reaches D₅₀ <0.8 µm and D₉₀ <1.5 µm as verified by laser diffraction. The milled dispersion is then spray-dried to produce a non-dusting granulate. For the dyer, the recommended application rate in exhaust dyeing of woven polyester is 1.0–3.0% o.w.f. at a liquor ratio of 1:10, holding at 130°C for 45–60 min in a high-temperature beam dyeing machine. The dyed fabric is subjected to reduction clearing with sodium dithionite (2 g/L) and NaOH at 70°C for 20 min to remove surface-deposited dye. The dye complies with the ZDHC Manufacturing Restricted Substances List V3.1, OEKO-TEX Standard 100 (Annex 4 limits for arylamines), and REACH Annex XVII (entries 43 and 72). The terminal product is a standardized blue disperse dye, typically supplied as a 200% or 300% strength powder, evaluated for key fastness using the test methods shown in the attribute matrix.

    Test Standard Test Condition Fastness Rating
    ISO 105-B02 Xenon arc, 20 AFU 6-7
    ISO 105-C06 C2S 60°C, 30 min 4-5
    ISO 105-P01 180°C, 30 s 4

    Incorporation of 6-Amino-7-bromobenzothiazole as an asymmetric, halogenated diamine monomer into aromatic polyimides yields films with a refractive index (nTE) exceeding 1.72 at 633 nm and a birefringence below 0.008, making the polymer suitable as a planarisation layer in flexible organic light-emitting diode (OLED) stacks. The polymerization procedure demands absolute stoichiometric control: the diamine and a selected dianhydride (typically 2,2′-bis(3,4-dicarboxyphenyl)hexafluoropropane dianhydride (6FDA) or pyromellitic dianhydride (PMDA)) are dissolved in anhydrous N-methyl-2-pyrrolidone (NMP) at 15–20 wt% total solids, with the diamine:dianhydride molar ratio held at 1.000:0.995–1.000 to achieve a target inherent viscosity of 0.8–1.2 dL/g (0.5 g/dL in NMP, 30°C). The exothermic polyaddition is carried out in a jacketed reactor with thorough mechanical stirring, maintaining the internal temperature at 10–15°C for 6–8 hours under a dry nitrogen purge to prevent acylation side reactions. The resulting polyamic acid (PAA) solution is degassed under vacuum and cast onto a glass carrier plate using a slot-die coater with a lip gap of 350–400 µm; the wet film is sequentially heated to 80°C (30 min), 150°C (30 min), 250°C (60 min), and finally 300°C (30 min) under flowing nitrogen to complete thermal imidisation. The free-standing film exhibits a glass transition temperature (Tg) in the range 285–320°C as measured by DMA (ASTM D7028). The product is employed as a transparent flexible substrate or as a planarisation and passivation layer in roll-to-roll fabrication of active-matrix OLED displays. Regulatory compliance is demonstrated via RoHS 2011/65/EU verification on homogeneous materials, adherence to IPC 4203A for flexible base dielectrics, and UL 94 V-0 flame classification for the completed circuit substrate. Finished articles include foldable smartphone display films and high-temperature dielectric interlayers.

    Safener-Precursor Engineering and Acetolactate Synthase Inhibition Pathways

    Within the crop protection sector, the benzothiazole ring acts as a bioisostere for the widely exploited pyrimidine and triazine scaffolds in ALS-inhibiting herbicides, and the 6-amino-7-bromo substitution pattern allows for regio-selective functionalisation at the C2-position to tailor phytotoxicity. The starting material is reacted with methyl chloroformate (1.05 eq) in a biphasic mixture of dichloromethane and saturated aqueous NaHCO₃ at 0–10°C to form the corresponding methyl carbamate, which is isolated as a solid of >98.5% purity by GLC. This carbamate is subsequently treated with a substituted aniline in refluxing toluene in the presence of 0.1 eq 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) as a catalyst to generate the target sulfonylurea herbicide precursor. The reaction mass is vacuum-stripped of solvent, and the product is triturated with isopropanol to remove unreacted aniline; the process delivers a typical yield of 82–88% over two steps. The technical-grade active ingredient is then formulated into a water-dispersible granule (WG) by blending with a wetting agent (alkylnaphthalene sulfonate, 3–5 wt%), a disintegrant (sodium bicarbonate), and a carrier (kaolin) before extrusion and spheronisation at 60°C inlet air temperature. The final product is a selective post-emergence herbicide for broadleaf weed control in cereal crops, applied at 15–45 g a.i./ha. Every shipment of the 6-Amino-7-bromobenzothiazole intermediate destined for an agrochemical use pattern must be accompanied by certification of compliance with the FAO specification for relevant impurities (water content <0.5%, sulphated ash <0.1%), US EPA 40 CFR Part 158 data requirements for product chemistry, and the European Regulation (EC) No 1107/2009 Annex II data points for the five-batch analysis. Analytical reference standards are cross-checked against CIPAC methods MT 18.1 and MT 46.3. During the development of the manufacturing process, particular attention is given to the containment of brominated dust and the monitoring of airborne concentrations to below the OEL of 0.1 mg/m³ (as total dust) per the supplier’s safety data sheet, in accordance with local occupational health provisions.

    If the Diffusion Length Must Be Sub-45 nm, Bromobenzothiazole-Derived PAGs Offer a Pathway

    For 193 nm immersion lithography at half-pitch nodes below 45 nm, the photoacid generator (PAG) must exhibit an exceptionally low diffusion coefficient inside the deprotected resist matrix to preserve acid latent image contrast. A novel class of non-ionic PAGs synthesised from 6-Amino-7-bromobenzothiazole takes advantage of the compound’s aromatic bromide for subsequent generation of a 7-sulfonate photoacid precursor through Ullmann-type coupling or aromatic nucleophilic substitution. In a typical PAG synthesis, the primary aromatic amine is diazotised with nitrous acid at -5 to 0°C and then treated with a perfluoroalkyl sulfonamide to yield a thermally stable diazosulfone. The isolated PAG is blended into a positive-tone 193 nm resist formulation at a solid weight loading of 5.0–12.0 wt% relative to the total polymer solids. The resist mixture consists of a methacrylate co-polymer bearing acid-labile adamantyl ester groups, the benzothiazole PAG, a secondary amine quencher (0.5–2.0 wt%), and propylene glycol methyl ether acetate (PGMEA) as the spin-casting solvent. The formulation is filtered through a 0.02 µm UPE membrane and applied on a 300 mm silicon wafer using a TEL CLEAN TRACK ACT 12 coater/developer system, with dynamic dispense at 1500 rpm to achieve a film thickness of 110±5 nm. Soft bake is carried out at 110°C for 90 seconds on a proximity hot plate, followed by exposure through an attenuated phase-shift mask on an ASML TWINSCAN NXT:1950i scanner at 193 nm, a numerical aperture of 1.35, and an exposure dose ranging 18–35 mJ/cm². After a post-exposure bake at 120°C for 60 seconds, the wafer is developed in 0.26 N tetramethylammonium hydroxide for 30 seconds and rinsed. The resulting resist patterns demonstrate a critical dimension of 38 nm dense lines with line-width roughness (LWR) below 3.5 nm (3σ). The composition adheres to SEMI C63 guidelines for resist quality, and halogen content is verified via combustion ion chromatography (IEC 62321) in support of the manufacturer’s REACH compliance obligations. The final product is a custom-developed 193 nm photoresist supplied in 1 L NOWPak canisters, validated for use in advanced logic foundry processes.

    Formulation Component Loading (wt% of total solids)
    Polymer matrix (e.g., polyhydroxystyrene) 80–90%
    Benzothiazole-derived PAG 5–12%
    Quencher base 0.5–2.0%
    Surfactant 50–100 ppm

    Modification at the 7-Position of the Benzothiazole Fluorophore Enables Ratiometric Hg²⁺ Detection

    The inherent fluorescence of the benzothiazole chromophore is strongly modulated by the nature of the substituent at the 7-position, and 6-Amino-7-bromobenzothiazole serves as the key building block for constructing ratiometric Hg²⁺-selective probes through post-functionalisation with a xanthene-dye fragment. In the synthetic protocol, a DMF solution of the benzothiazole amine is treated with rhodamine B isothiocyanate or an activated rhodamine B carboxylic acid derivative at a molar ratio of 1:1.2 with 1.1 equivalents of HBTU as the coupling activator and 2.5 equivalents of N,N-diisopropylethylamine at ambient temperature for 12 hours. The crude conjugate is purified by silica gel flash chromatography (eluent CH₂Cl₂/MeOH 95:5), yielding a pale pink solid. A stock solution of the probe is prepared at 1.0 mM in DMSO, and working dilutions of 10 µM in HEPES-buffered aqueous acetonitrile (pH 7.2) are employed for spectroscopic titration. Upon incremental addition of Hg²⁺ (added as perchlorate salt, 0–1.5 equivalents), the emission maximum shifts from 480 nm to 585 nm due to Hg²⁺-promoted spirolactam ring-opening of the rhodamine moiety, enabling ratiometric quantification with a detection limit of 12 nM. The manufacturing process for the intermediate is conducted under the quality management system of ISO 9001:2015; final probe kits sold for environmental analysis must comply with the performance requirements of ISO 17378-2 for mercury determination in water and analogous US EPA method 245.1. Downstream processable formats include the impregnation of the probe into sol-gel derived ormosil thin films on glass slides, which are sealed into thermoplastic cartridges for use with a portable fluorescence photometer. The commercial product is a disposable mercury-sensing card containing four indicator spots, each coated with 5 µL of a 0.5 wt% PVC-membrane cocktail incorporating the benzothiazole-rhodamine conjugate and a plasticiser.

    Free Quote

    Competitive 6-Amino-7-Bromobenzothiazole prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    6-Amino-7-bromobenzothiazole (CAS 256437-10-2) is a heterobicyclic aromatic amine in which the benzothiazole nucleus is substituted with a primary amino group at the 6-position and a bromine atom at the 7-position. The molecular formula is C₇H₅BrN₂S and the monoisotopic mass calculates to 227.9357 g·mol⁻¹. Commercial supply typically employs model designators BTZ-671-NH2-7Br for research-grade material and BTZ-671-NH2-7Br-HP for custom synthesis intermediates processed through additional recrystallization and activated-carbon treatment. The specifications in Table 1 derive from the release testing of a production campaign conducted in a 20‑L glass-lined reactor using a 2‑amino‑5‑bromobenzenethiol cyclization route, followed by neutralization, filtration, and vacuum drying at 45 °C for 8 h.

    Table 1 — Typical release specifications and analytical methods
    ParameterSpecificationMethod
    AppearancePale yellow to light brown crystalline powderVisual inspection (Ph.Eur. 2.2.1)
    Assay (HPLC)97.0% (area normalization)HPLC-UV 254 nm; C18 column (5 µm, 4.6 × 250 mm); mobile phase acetonitrile/0.1% TFA 40:60; flow rate 1.0 mL·min⁻¹
    Melting point196–200 °C (decomposition)Capillary method, heating rate 2 °C·min⁻¹ (USP <741>)
    Moisture (Karl Fischer)0.5%Coulometric titration (Ph.Eur. 2.5.12)
    Residual palladium10 ppmICP-MS after microwave digestion (Ph.Eur. 2.4.20)
    Heavy metals (total)20 ppmPh.Eur. method 2.4.8
    Loss on drying0.3% (105 °C, 2 h)USP <731>
    Residual solvents (GC)Ethyl acetate ≤ 500 ppm, ethanol ≤ 200 ppmHeadspace GC-FID (USP <467>)

    The compound functions as a bifunctional building block: the amino group undergoes diazotization, acylation, and Schiff-base condensation, while the C—Br bond participates in palladium-catalyzed cross-coupling (Suzuki-Miyaura and Buchwald-Hartwig) and copper-mediated Ullmann reactions. It has been incorporated into thioflavin-T analogues for β‑amyloid imaging probes, kinase inhibitor scaffolds requiring C‑7 aryl extension, and heterocyclic azo dyes with enhanced molar extinction coefficients. A primary differentiation from the 6‑amino‑5‑bromobenzothiazole isomer (CAS 1588441-10-4) is the para relationship of the amino and bromo substituents, which redirects electrophilic aromatic substitution to the 4- and 5‑positions and alters the electronic environment of the bromine during oxidative addition with Pd(0).

    Why Does the 7‑Bromo Regioisomer Exhibit Altered Reactivity Compared to 5‑ and 6‑Bromo Analogs?

    In 6‑amino‑7‑bromobenzothiazole the amino group resides ortho to the sulfur heteroatom and para to the bromine. This connectivity raises the electron density on C‑7 through resonance donation, which can decelerate the initial oxidative addition step with zerovalent palladium relative to an unactivated aryl bromide, yet simultaneously stabilizes the Pd(II) intermediate once formed. In a model Suzuki coupling with phenylboronic acid (1.2 eq), Pd(PPh₃)₄ (2 mol%), and K₂CO₃ (2 eq) in 1,4‑dioxane/water (4:1 v/v) at 80 ± 2 °C for 6 h, the 7‑bromo isomer returned an isolated yield of 78% after column chromatography. The 5‑bromo isomer (amino meta to Br) gave 65% under identical conditions, and the 6‑bromo isomer (amino ortho to Br, bromine para to sulfur) afforded 82%. The difference is consistent with the weakening of the C—Br bond dipole in the para-amino case, as reflected in Hammett σₚ values for the NH₂ group (−0.66) contrasting with σₘ (−0.16).

    Process-scale Suzuki reactions on 50‑mol batches in a 100‑L Hastelloy reactor have demonstrated that the 7‑bromo isomer requires tighter temperature control than the 6‑bromo analogue. The onset of exothermic debromination—leading to 6‑aminobenzothiazole impurity—was detected by DSC at 172 °C for the 7‑bromo compound (heating rate 5 °C·min⁻¹, sealed pan), whereas the 5‑bromo isomer shows a higher decomposition threshold at 198 °C. Consequently, high-temperature couplings above 110 °C are discouraged for the 7‑bromo regioisomer unless microwave irradiation with precise power control is employed.

    Palladium Scavenging and Metal Purity Thresholds

    Post-reaction palladium levels in crude 6‑amino‑7‑bromobenzothiazole isolated from bromocyclization can exceed 35 ppm when Pd/C is used in an earlier hydrogenation step. ICH Q3D guidelines (oral exposure, elements of class 1B) limit palladium to a permitted daily exposure of 100 µg·day⁻¹, which translates to a concentration cap of 10 ppm in a drug substance assumed at 10 g·day⁻¹ dosage. To meet this benchmark, three pilot batches (lot #BRN‑2104‑A through C) were treated with N‑acetyl‑L‑cysteine functionalized silica (loading 1.5 wt% relative to substrate) in ethanol/water at 50 °C for 3 h. ICP‑MS analysis (Agilent 7900, method detection limit 0.01 ppb) before and after scavenging showed residual Pd dropping from a mean of 38 ppm (RSD 12%, n=9) to 2.8 ppm (RSD 8%). The procedure did not alter the HPLC purity profile beyond a 0.2% decrease in main peak area. Users integrating 6‑amino‑7‑bromobenzothiazole into API manufacturing under cGMP should verify the absence of thiocyanate-extractable Pd species per USP <232> and conduct spiked recovery experiments if the matrix contains competing chelators.

    A comparative assessment of regioisomeric 6‑amino‑bromobenzothiazoles was undertaken to quantify the effect of bromine position on the photophysical properties of derived fluorescent thioflavin-T analogs. Each isomer was reacted with 2‑(dimethylamino)benzaldehyde under identical Knoevenagel conditions (piperidine catalysis, ethanol reflux, 12 h), and the crude products were purified by recrystallization from acetonitrile. Table 2 collates the absorption and emission maxima together with the fluorescence quantum yields determined against a quinine sulfate standard (0.1 M H₂SO₄, Φ = 0.54). The data reveal that the 7‑bromo‑derived fluorophore exhibits a 15 nm bathochromic shift in emission compared to the 5‑bromo derivative, attributable to the extended π‑conjugation permitted by the para-amino arrangement. The relative quantum yield lacks a monotonic correlation with the C—Br position, suggesting that non‑radiative decay pathways are influenced by the proximity of the bromine to the thiazole sulfur.

    Table 2 — Photophysical and synthetic yields of regioisomeric 6‑amino‑bromobenzothiazole-derived fluorophores
    Starting isomerλabs (nm) in MeOHλem (nm)ΦIsolated yield (%)
    6‑Amino‑7‑bromobenzothiazole4125280.4871
    6‑Amino‑5‑bromobenzothiazole4035130.4162
    6‑Amino‑4‑bromobenzothiazole3985060.3958
    6‑Amino‑2‑bromobenzothiazole4205350.5276

    In medicinal chemistry campaigns where 6‑amino‑7‑bromobenzothiazole is employed as a hinge-binding fragment for kinase targets, the substitution pattern affects not only the geometry of the biaryl torsion angle after cross-coupling but also the metabolic stability of the amino group. In‑vitro microsomal incubation (human liver microsomes, 1 mg·mL⁻¹, NADPH regenerating system, 37 °C) of the unsubstituted core gives a half‑life of 48 min, whereas N‑acetyl‑6‑amino‑7‑bromobenzothiazole demonstrates a half‑life of 127 min, indicating substantial N‑acetylation risk. The 5‑bromo isomer, by contrast, exhibited a half‑life of 89 min for the acetylated derivative, suggesting that the position of the halogen influences the rate of phase‑II conjugation. These findings reinforce that 7‑bromo substitution cannot be selected solely for synthetic convenience; it impacts the ADME profile in ways that differ measurably from the 5‑ and 6‑bromo congeners.

    When Bromide Abstraction Competes with Desired Aminolysis in Nucleophilic Displacement

    At elevated temperatures above 120 °C, primary and secondary amines can attack the C‑7 bromine of 6‑amino‑7‑bromobenzothiazole through an SNAr mechanism, yielding the 7‑amino derivative and free bromide. This side reaction becomes the dominant pathway when using nucleophilic bases such as pyrrolidine or morpholine in dipolar aprotic solvents. In a 500‑mL jacketed glass reactor, charging pyrrolidine (3 eq) in DMF at 130 °C for 2 h resulted in 92% conversion to 6‑amino‑7‑(pyrrolidin‑1‑yl)benzothiazole; the desired 7‑arylated product from a competitive Suzuki coupling fell below 5%. Therefore, telescoped processes that perform consecutive Buchwald-Hartwig amination on the same ring must reverse the sequence: the C—N bond at the 7‑position is introduced via cross-coupling after the amine handle has been protected as an acetamide (Ac₂O, pyridine, 0 °C to r.t.). Deprotection with 6 M HCl at 70 °C for 4 h restores the 6‑amino group without displacing the newly installed 7‑aryl or 7‑amino substituent, provided residual moisture is kept below 0.2% in the deprotection solvent.

    Production staff must observe a strict processing window of ± 5 °C during the amination step when using unprotected 6‑amino‑7‑bromobenzothiazole. Batch records from a 3‑kg campaign show that an overshoot to 135 °C for 15 min raised the 7‑(pyrrolidino) impurity from 0.8% to 4.2% by HPLC, rendering the batch out of specification for subsequent GMP steps. This sensitivity is absent in the 2‑amino‑7‑bromobenzothiazole isomer, where the amino group is electronically isolated from the halogen on the phenyl ring, underscoring why 6‑amino‑7‑bromobenzothiazole demands dedicated reaction calorimetry before scale‑up.

    Storage stability studies on three consecutive pilot batches stored at 25 °C/60% RH in double polyethylene‑lined fibre drums showed moisture uptake exceeding 1.5% after 6 months unless containers were resealed under dry nitrogen and stored with silica gel desiccant packs. Humidity‑induced degradation manifests as a progressive discoloration to dark brown, accompanied by a drop in HPLC assay of 0.8–1.2% per month at 40 °C/75% RH. A forced‑degradation study under ICH Q1A(R2) conditions confirmed that the principal degradation product is 6‑amino‑7‑hydroxybenzothiazole, formed via hydrolytic debromination. The material is incompatible with strong oxidizing agents (exothermic reaction with H₂O₂ 30%, onset at 85 °C by DSC), strong acids (ring‑opening at pH < 2, detectable by sulfide odor), and long‑term contact with primary amines at ambient temperature. Pre‑drying in a vacuum oven (10 mbar, 40 °C) for 4 h is required if the material has been exposed to ambient laboratory air with relative humidity above 60%. The substance is classified as a non‑dangerous good for transport under DOT and ADR, but local REACH registration within the EU (EC number not yet finalized as of the current reporting cycle) may impose control banding for laboratory use.